The Benefits of Avoiding Cancer (or Dying from Cancer): Evidence from a Four-country Study

Anna Alberini and Milan Ščasný (milan.scasny@czp.cuni.cz)
Additional contact information
Anna Alberini: AREC, University of Maryland and FEEM

No 2017.01, Working Papers from Fondazione Eni Enrico Mattei

Abstract: We use stated-preference methods to estimate the cancer Value per Statistical Life (VSL) and Value per Statistical Case (VSCC) from a representative sample of 45-60-year olds in four countries in Europe. We ask respondents to report information about their willingness to pay for health risk reductions that are different from those used in earlier valuation work because they are comprised of two probabilities—that of getting cancer, and that of dying from it (conditional on getting it in the first place). The product of these two probabilities is the unconditional cancer mortality risk. Our hypothetical risk reductions also include two qualitative attributes—quality-of-life impacts and pain. The results show that respondents did appear to have an intuitive grasp of compound probabilities, and took into account each component of the unconditional cancer mortality risk when answering the valuation questions. We estimate the cancer VSL to be between € 1.9 and 5.7 million, depending on whether the (unconditional) mortality risk was reduced by lowering the chance of getting cancer, increasing the chance of surviving cancer, or both. The VSCC is estimated to be up to € 0.550 million euro, and its magnitude depends on the initial (conditional) cancer mortality and on the improvement in survival. We interpret these as “pure” mortality and cancer risk values, stripped of morbidity, pain or quality-of-life effects. The survey responses show that impacts on daily activities and pain have little or no effect on the WTP to reduce the adverse health risks.

Keywords: Cancer Risk; Value of a Statistical Life; Value of a Statistical Case of Cancer; Mortality Risk Reduction; Stated Preferences (search for similar items in EconPapers)
JEL-codes: I18 J17 K32 Q51 (search for similar items in EconPapers)
Date: 2017-01
New Economics Papers: this item is included in nep-hea
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://feem-media.s3.eu-central-1.amazonaws.com/w ... oads/NDL2017-001.pdf (application/pdf)

Related works:
Journal Article: The benefits of avoiding cancer (or dying from cancer): Evidence from a four- country study (2018)
Working Paper: The Benefits of Avoiding Cancer (or Dying from Cancer): Evidence from a Four-country Study (2017)
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:fem:femwpa:2017.01

Access Statistics for this paper

More papers in Working Papers from Fondazione Eni Enrico Mattei Contact information at EDIRC.
Bibliographic data for series maintained by Alberto Prina Cerai (alberto.prinacerai@feem.it this e-mail address is bad, please contact repec@repec.org).